Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Ratiopharm Gmbh
Ratiopharm Gmbh Graf arco strasse 3

Ratiopharm Gmbh patents

Recent patent applications related to Ratiopharm Gmbh. Ratiopharm Gmbh is listed as an Agent/Assignee. Note: Ratiopharm Gmbh may have other listings under different names/spellings. We're not affiliated with Ratiopharm Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Ratiopharm Gmbh-related inventors

Date Ratiopharm Gmbh patents (updated weekly) - BOOKMARK this page
06/29/17Pharmaceutical composition for the treatment of parkinson's disease
05/18/17Solid state forms of sofosbuvir
05/04/17Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds
02/02/17Mmf-derivatives of ethyleneglycols
01/19/17Pharmaceutical composition
01/19/17Solid state forms of sofosbuvir
01/05/17Derivatives of polyhydroxy compounds
12/22/16Film coated pellets
12/08/16Solid state forms of vemurafenib hydrochloride
11/10/16Derivatives of tartaric acid
10/20/16Liquid formulation of fsh
10/20/16Liquid formulation of fsh
10/20/16Liquid formulation of fsh
10/20/16Method for purifying recombinant fsh
10/06/16Bis-mmf derivatives
07/28/16Prodrugs of monomethyl fumarate (mmf)
06/30/16Medicament comprising a pharmaceutical combination of drugs
05/26/16Dolutegravir salts
05/19/16Composition comprising tapentadol in a dissolved form
05/05/16Solid pharmaceutical dosage form
04/14/16Method for the production of a medicament containing tadalafil
03/24/16Method for producing dosage form comprising odanacatib
03/10/16Solid state forms of vemurafenib and vemurafenib salts
02/04/16Solid pharmaceutical dosage form of dolutegravir
01/28/16Dosage form comprising crizotinib
01/21/16Solid state forms of vemurafenib hydrochloride
10/22/15Prodrugs of monomethyl fumarate (mmf)
10/01/15Dosage forms comprising apixaban and matrix former
09/03/15Oral dosage forms for modified release comprising ruxolitinib
08/20/15Crystalline forms of afatinib di-maleate
07/02/15Solid state form of vemurafenib choline salt
06/04/15Desfesoterodine salts
05/14/15Compacted moxifloxacin
05/07/15Liquid formulation of g-csf
04/23/15Dosage form comprising non-crystalline lopinavir and crystalline ritonavir
02/05/15Solid ivabradine-containing composition
01/15/15Dosage form comprising lopinavir and ritonavir
12/04/14Salt of ivabradine with adipic acid
09/04/14Pharmaceutical composition comprising dapagliflozin and cyclodextrin
05/29/14Solid pharmaceutical dosage form of ticagrelor
04/03/14Composition and tablet comprising raltegravir
03/27/14Ophthalmic preparation comprising a pgf2alpha analogue
03/13/14Method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant
12/26/13Oral dosage forms for modified release comprising tasocitinib
12/26/13Solid composition containing the ingredient rasagiline
10/24/13Transdermal therapeutic system (tts) comprising rotigotine
08/29/13Dry processing of atazanavir
06/20/13Solid ivabradine-containing composition
06/06/13Oral dosage form of deferasirox
05/09/13Solid tapentadol in non-crystalline form
04/25/13Fingolimod in the form of a solid solution
04/25/13Melt-granulated fingolimod
04/18/13Method of preparing an oral dosage form comprising fingolimod
04/04/13Ivabradine-containing pharmaceutical composition
03/07/13Rapid release irbesartan-containing pharmaceutical composition
02/07/13Prasugrel in micronized, crystalline form and pharmaceutical composition thereof
01/31/13Solid pharmaceutical dosage form
11/22/12Orodispersible tablet containing compacted sildenafil base
11/15/12Escitalopram and solid pharmaceutical composition comprising the same
10/25/12Melt-granulated cinacalcet
10/11/12Composition comprising fesoterodine and fiber
09/13/12Pharmaceutical compositions comprising rivaroxaban
08/23/12Orally disintegrating pharmaceutical dosage form containing aripiprazole
08/09/12Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptin
Patent Packs
07/26/12Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
07/19/12Process for producing fingolimod salts
05/24/12Desfesoterodine in the form of a tartaric acid salt
05/17/12Dry processing of retigabine
03/22/12Melting tablet containing a sildenafil salt
03/08/12Retigabine tablets, preferably having modified release
03/01/12Solid retigabine in non-crystalline form
01/26/12Amorphous ambrisentan
01/19/12Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy] phenyl]-6-[5[[[2-(methylsulfonyl) ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
01/12/12Compacted cinacalcet
12/22/11Solid composition containing the ingredient rasagiline
12/15/11Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
12/08/11Pharmaceutical compositions comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
12/01/11Compacted moxifloxacin
12/01/11Process for preparing pyrimidine derivatives
Patent Packs
11/17/11Oral dispersible tablet
08/04/11Bitablets comprising compacted polyallylamine polymer and the production thereof
08/04/11Pharmaceutical formulation for lowering pulmonary blood pressure
08/04/11Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid
07/07/11Directly pressed aliskiren tablets
03/17/11Process for preparing pentanoic diacid derivatives
02/10/11Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
01/13/11Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
12/23/10Escitalopram and solid pharmaceutical composition comprising the same
12/09/10Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
11/18/10Pharmaceutical formulation comprising ezetimibe
09/16/10Novel salts of the active substance rasagiline
08/26/10Process for the preparation of valsartan and intermediate products
07/15/10Method for the production of a medicament containing tadalafil
06/24/10Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate
06/17/10Stabilised pharmaceutical composition containing pregabaline
06/03/10Method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant
04/29/10Pharmaceutical compositions comprising irbesartan
09/03/09Rapid release irbesartan-containing pharmaceutical composition
06/11/09Stereoselective the production of (r)-dimepranol
04/30/09Method for the production of losartan
06/13/13Dabigatran etexilate-containing pharmaceutical composition

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Ratiopharm Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ratiopharm Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by